Cassie Houtz, PhD (she/her/hers) is a postdoctoral fellow of Ethical, Legal, and Social Implications of Genetics and Genomics in the Perelman School of Medicine’s Department of Medical Ethics & Health Policy. Her interests lie in disability bioethics, philosophy of medicine, and the “quality of life.” As a postdoctoral fellow, she is working on two primary research areas: (1) ethical and social issues related to obesity genetics research, testing, and treatment and (2) ethical dilemmas in rare pediatric genetic diseases, especially leukodystrophies. She received her PhD in the study of religion from Harvard University, where she studied the intersections of philosophical, religious, and biomedical conceptions of what it means to live a “good life.”
Associate Fellow
Cassie Houtz, PhD
- Postdoctoral Fellow, Ethical, Legal, and Social Implications of Genetics and Genomics, Perelman School of Medicine
Related Content
Worker Wages Stagnate as Medicaid Home Care Spending Rises
Raising Reimbursement Rates and Wages Would Support a Stable Workforce and Better Care, LDI Fellows Say
Five LDI Senior Fellows Win Grants to Study Transitional Housing for People with HIV
Project Funded Through a Partnership of LDI, Penn CFAR and the City of Philadelphia
Rochelle Walensky Reflects on Her Work as Former Biden CDC Director
Looking Back at a Tumultuous Time in a Penn LDI Fireside Chat
Mark Cuban Explains His Battle Against Pharmacy Benefit Managers
Report from His Penn Fireside Chat with Ezekiel Emanuel about Drug Pricing
Policy Insights to Improve WIC and SNAP Access
Caregivers of Children in Low-Income Families Cite Key Barriers and Solutions for WIC and SNAP
In The Media KFF Health News
Two Years Into Philly’s Sugary Drink Tax, No Major Change In Kid’s Obesity
Interview
In The Media WHYY
Is The American Shopping Mall Dying? The Philadelphia Area Has Seen Its Fair Share Disappear
Interview
In The Media MSN
Online Reviews of Health Care Facilities Drop Significantly After COVID-19 Pandemic
Interview
In The Media Healio
Older Adult’s Receipt of Guideline-Concordant Breast Cancer Care Varies By Race
Interview